Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linda Kerkmeijer

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 16, 2021
Implementation of MR-linac and proton therapy in two radiotherapy departments in The Netherlands: Recommendations based on lessons learnedMaria Jacobs, Linda Kerkmeijer, Dirk de Ruysscher, et al.
Frontiers in Oncology|May 28, 2021
Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy: The Next Step in the Treatment of Renal Cell CarcinomaBrian Keller, Anna M E Bruynzeel, Chad Tang, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|April 28, 2006
Guidelines following hydatidiform mole: a reappraisalLinda Kerkmeijer, Sabien Wielsma, Sabien Wiesma, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|April 28, 2006
Persistent trophoblast disease following partial molar pregnancySabien Wielsma, Sabien Wiesma, Linda Kerkmeijer, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 14, 2025
Prostate motion in magnetic resonance imaging-guided radiotherapy and its impact on marginsJohannes Kusters, René Monshouwer, Peter Koopmans, et al.
Cancers|December 6, 2018
Focal Salvage Treatment of Radiorecurrent Prostate Cancer: A Narrative Review of Current Strategies and Future PerspectivesMarieke van Son, Max Peters, Marinus Moerland, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 6, 2019
Stereotactic body radiation therapy with optional focal lesion ablative microboost in prostate cancer: Topical review and multicenter consensusCédric Draulans, Robin De Roover, Uulke A van der Heide, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 7, 2020
Optimal <sup>68</sup>Ga-PSMA and <sup>18</sup>F-PSMA PET window levelling for gross tumour volume delineation in primary prostate cancerCédric Draulans, Robin De Roover, Uulke A van der Heide, et al.
Practical Radiation Oncology|May 4, 2021
<sup>68</sup>Ga-PSMA-11 PET, <sup>18</sup>F-PSMA-1007 PET, and MRI for Gross Tumor Volume Delineation in Primary Prostate Cancer: Intermodality and Intertracer VariabilityCédric Draulans, Floris Pos, Robert J Smeenk, et al.
European Urology Oncology|February 7, 2025
Results of Stereotactic Body Radiation Therapy for Primary Renal Cell Carcinoma in a Large Multicenter SeriesLudwige Abancourt, Muhammad Ali, Magali Quivrin, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 16, 2021
Implementation of MR-linac and proton therapy in two radiotherapy departments in The Netherlands: Recommendations based on lessons learnedMaria Jacobs, Linda Kerkmeijer, Dirk de Ruysscher, et al.
Frontiers in Oncology|May 28, 2021
Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy: The Next Step in the Treatment of Renal Cell CarcinomaBrian Keller, Anna M E Bruynzeel, Chad Tang, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|April 28, 2006
Guidelines following hydatidiform mole: a reappraisalLinda Kerkmeijer, Sabien Wielsma, Sabien Wiesma, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|April 28, 2006
Persistent trophoblast disease following partial molar pregnancySabien Wielsma, Sabien Wiesma, Linda Kerkmeijer, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 14, 2025
Prostate motion in magnetic resonance imaging-guided radiotherapy and its impact on marginsJohannes Kusters, René Monshouwer, Peter Koopmans, et al.
Cancers|December 6, 2018
Focal Salvage Treatment of Radiorecurrent Prostate Cancer: A Narrative Review of Current Strategies and Future PerspectivesMarieke van Son, Max Peters, Marinus Moerland, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 6, 2019
Stereotactic body radiation therapy with optional focal lesion ablative microboost in prostate cancer: Topical review and multicenter consensusCédric Draulans, Robin De Roover, Uulke A van der Heide, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 7, 2020
Optimal <sup>68</sup>Ga-PSMA and <sup>18</sup>F-PSMA PET window levelling for gross tumour volume delineation in primary prostate cancerCédric Draulans, Robin De Roover, Uulke A van der Heide, et al.
Practical Radiation Oncology|May 4, 2021
<sup>68</sup>Ga-PSMA-11 PET, <sup>18</sup>F-PSMA-1007 PET, and MRI for Gross Tumor Volume Delineation in Primary Prostate Cancer: Intermodality and Intertracer VariabilityCédric Draulans, Floris Pos, Robert J Smeenk, et al.
European Urology Oncology|February 7, 2025
Results of Stereotactic Body Radiation Therapy for Primary Renal Cell Carcinoma in a Large Multicenter SeriesLudwige Abancourt, Muhammad Ali, Magali Quivrin, et al.
Pageof 2